Johnson & Johnson (JNJ) Stock: Buy, Sell, or Hold?
$280.41
-0.37 (-0.13%)
▼
5d:
+1.48%
30d:
+12.79%
90d:
+6.99%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Oct 13, 2026
0d
Protect JNJ Gains
Updated Nov 11, 12:00 AM ET
QUANTITATIVE VERDICT
WAIT
LOW Confidence (27%)
Quality Score
45/100
Position
EXTENDED
30-Day Fair Range
$255.47 – $274.59
Position: EXTENDED
Forward P/E & Valuation
24.1x
STRETCHED
vs 19.7x historical avg
Wall Street Target
$279.41
-0.4% vs target
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$265.28 / $283.25
Trend: Strong Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: JNJ shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When JNJ Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$281.93
Based on 4.3% avg growth
INTRINSIC VALUE TODAY
$175.06
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 19.7x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: JNJ is currently trading at $280.41, which is considered extended relative to its 30-day fair value range of $255.47 to $274.59. From a valuation perspective, the stock is trading at a premium (Forward PE: 24.1) compared to its historical average (19.7). At these levels, the market is pricing in 7.0% annual earnings growth.
Technical Outlook: Technically, JNJ is in a strong uptrend. The price is approaching resistance at $283.25. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: JNJ scores 33/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, JNJ is in a strong uptrend. The price is approaching resistance at $283.25. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: JNJ scores 33/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$255.47 -
$274.59
Company Quality Score
45/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
27.1%
Trading Range & Key Levels
30-Day Trading Range
$255.47 -
$274.59
Current vs Trading Range
EXTENDED
Support Level
$265.28
Resistance Level
$283.25
Current Trend
Strong Uptrend
Technical data as of
Nov 11, 2026
Protect Your Profits
Holding JNJ? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanQuantitative Signal Breakdown
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (33/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($279.41)
- BULLISH: Expecting earnings turnaround to 7.0% growth with 5.9% revenue growth
- WARNING: Composite score 45/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
24.13
Wall Street Target
$279.41
(-0.4%)
Revenue Growth (YoY)
5.9%
Earnings Growth (YoY)
-95.9%
Profit Margin
16.2%
Valuation Premium vs History
+7.0% premium
PE vs Historical
24.1 vs 19.7
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+7.0%
(market-implied from PE analysis)
1-Year Target
$300.04
(+7%)
2-Year Target
$321.04
(+15%)
3-Year Target
$343.51
(+23%)
3-Yr Target (if PE normalizes)
(PE: 24→20)
PE COMPRESSION
$280.49
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 24.1, Growth: 4.5%)
$320.19
(+14%)
Base:
(SPY PE: 19.9, Growth: 4.5%)
$263.56
(-6%)
Bear:
(PE: 16.9, Growth: 4.5%)
$224.03
(-20%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (43x PE), but valuation improves significantly next year (24x PE) as earnings recover.
Trailing PE: 42.61 | Current EPS (TTM): $6.59
Bull Case
$544.72
(+94%)
Analyst growth 76.4%, PE expands to 46.9
Base Case
$495.20
(+77%)
Market implied 76.4%, PE stable at 42.6
Bear Case
$190.93
(-32%)
Severe decline -20.0%, PE contracts to 36.2
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share JNJ Analysis
Share this live JNJ analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (JNJ)
Bullish
4 Retail Mentions
Reddit / WSB Comments
2
Bullish
StockTwits Volume
2 msgs
24h retail stream
Last Tracked
Nov 11, 2026
Daily AI digest
AI Retail Discussion Summary:
Traders on StockTwits express bullish sentiment ahead of Johnson & Johnson's ($JNJ) upcoming webcast and Regal Pivotal Registrational Phase 3 study PRIMARY Top Line data.
Key Retail Themes:
anticipation of positive data
optimism towards potential deals
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 1:29 AM ET
Data refreshes hourly during market hours. Next update: 2:29 AM
Data refreshes hourly during market hours. Next update: 2:29 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is JNJ showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Featured in Portfolios
JNJ is a key holding in these high-performance investment strategies.
Top Rated Drug Manufacturers - General Stocks
Top-rated stocks in Drug Manufacturers - General by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ABBV
AbbVie Inc |
STRONG BUY
29 analysts |
$306 | 48 HOLD |
|
BIIB
Biogen Inc |
BUY
36 analysts |
$266 | 43 HOLD |
|
LLY
Eli Lilly and Company |
STRONG BUY
31 analysts |
$1453 | 27 SELL |
|
MRK
Merck & Company Inc |
BUY
28 analysts |
$162 | 50 HOLD |
|
GILD
Gilead Sciences Inc |
STRONG BUY
28 analysts |
$175 | 37 SELL |
Advanced JNJ Option Strategies
Professional options setups generated by AI based on today's JNJ price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive JNJ Research Pages
